Shared decision making is an integral part of healthcare, says NICE
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
Search results
94 results
-
-
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
-
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
Final guidance from NICE recommends the PLASMA system
-
NICE is gearing up for the evaluation of further digital health technologies as pilot project produces first result
Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes
-
Speaking with one language: How using a common data model might speed up decision making
NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.
-
NICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
-
NICE, PHE and SACN publish rapid COVID-19 guidance on vitamin D
NICE, PHE and SACN have today published rapid guidance on vitamin D for COVID-19.
-
New LSE master's degree in Evaluation of Health Care Interventions and Outcomes
NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.
-
NICE and NIHR: working together to produce research with impact
Alice and Zoe discuss how the National Institute of Health Research (NIHR) and NICE work in partnership and identify key research priorities from NICE guidance.
-
Shared Learning Awards 2020: Winner announced
Virtual ceremony sees a project from Avon and Wiltshire Mental Health Partnership Trust voted winning submission
-
Innovative technology to detect abnormal heart rhythms recommended by NICE for NHS use while further data is collected
Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to be recommended for NHS use with the caveat that further data must be collected.
-
How NICE is improving patient safety
Annual patient safety update covers the period from September 2019 to September 2020
-
New option for people with difficult-to-treat multiple myeloma is recommended for use in Cancer Drugs Fund by NICE
Around 5,700 cases of multiple myeloma are diagnosed each year in the UK
-
NICE is getting ready for the end of the transition period after Brexit
NICE has a key role in evaluation and access to new and innovative products for the health system, playing an important role in ensuring the UK remains a destination of choice for the life sciences sector.
-
World Antimicrobial Awareness Week: developing new models for the evaluation and purchase of antimicrobials
Nick discusses World Antimicrobial Awareness Week and an important project he’s involved with to develop new models for the evaluation and purchase of antimicrobials.
-
NICE recommends innovative treatment for severe blood disorder for NHS use
Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.
-
How NICE guidance and resources can be used to evidence continuing professional development (CPD)
Registered social workers must demonstrate the use of evidence and research to inform their practice in order to meet professional standards. This is echoed in Social Work England’s continuing professional development (CPD) standards.
-
NICE draft guidance addresses the continuing debate about the best approach to the diagnosis and management of ME/CFS
NICE has today (10 November 2020) published its draft updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
-
NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia
More than 1,000 people each year will benefit from NICE's recommendation
-
NICE's methods of technology evaluation - presenting a case for change
NICE has today (6 November 2020) launched a public consultation on proposals for changes to the methods it uses to develop its guidance on medicines, medical devices and diagnostics.
-
NICE to become single point of access for Covid-19 guidance and advice
NICE has today (6 November) announced that it is to host a new, single point of advice on caring for people with Covid-19 and the management of Covid-19 in a variety of clinical settings.
-
Skin cancer drug not cost effective for routine NHS use
A consultation on the draft recommendations has now begun until Tuesday 24 November 2020
-
Shared Learning Awards 2020 finalist: Bronchiolitis: when less is more
The Shared Learning Awards recognise the brilliant work being done to put NICE guidance and standards into practice in a range of organisations, including NHS, local authorities, and the voluntary sector. The following work has been shortlisted for the NICE Shared Learning Awards 2020 and represents one of our 3 finalists.
-
Shared Learning Awards 2020 finalist: East of England Stroke Telemedicine Partnership
The Shared Learning Awards recognise the brilliant work being done to put NICE guidance and standards into practice in a range of organisations, including NHS, local authorities, and the voluntary sector. The following work has been shortlisted for the NICE Shared Learning Awards 2020 and represents one of our three finalists.
-
NICE recommends new treatment option for adults with obesity and non-diabetic hyperglycaemia who have a high risk of cardiovascular disease
All eligibility criteria must be met for Liraglutide to be offered
-
NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID-19
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have today (30 October 2020) given more details about the forthcoming guideline on post-COVID syndrome.
-
Shared Learning Awards 2020 finalist: Prescribing guidelines for patients with a first episode psychosis
The Shared Learning Awards recognise the brilliant work being done to put NICE guidance and standards into practice in a range of organisations, including the NHS, local authorities, and the voluntary sector. The following work has been shortlisted for the NICE Shared Learning Awards 2020 and represents one of our three finalists.
-
NICE announces start of review of nusinersen Managed Access Agreement
NICE has today (29 October 2020) announced that it has begun the process to review data collected as part of the Managed Access Agreement (MAA) for nusinersen (also called Spinraza and made by Biogen) for treating the rare genetic disorder spinal muscular atrophy (SMA).
-
Test people with womb cancer for inherited genetic condition, NICE says in new guidance
Research led by Professor Emma Crosbie, with Professor Gareth Evans and Dr Neil Ryan from The University of Manchester and Manchester University NHS Foundation Trust, showed the benefits of different testing strategies for Lynch syndrome in womb cancer cases in increasing diagnosis of the condition.
-
Inside NICE: My experience of the scholarship programme
Howard Ryland, National Institute of Health Research (NIHR) Doctoral Research Fellow at the Department of Psychiatry at the University of Oxford, discusses his experience as a NICE scholar.
-
NICE gears up to support World Evidence-based Healthcare Day
Inaugural World Evidence-based Healthcare (EBHC) Day takes place on Tuesday 20 October 2020
-
NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis
NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).
-
World Evidence-Based Healthcare Day: Using evidence to inform our recommendations
Dr Martin Allaby discusses World Evidence-Based Healthcare Day and how NICE uses evidence to inform our recommendations.
-
Evidence for HTA: Innovative methods for challenging times
Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of HTAi 2021 in the UK
-
NICE non-executive director Elaine Inglesby-Burke CBE awarded Damehood for services to nursing
Elaine has been honoured in the Queen’s birthday honours list to recognise her commitment to the profession
-
NICE proposes simplifying how medicines and medical devices are selected for evaluation.
As part of the work underway to review the methods and processes NICE uses to develop guidance on medicines, medical devices and diagnostics, NICE has launched a public consultation on proposals for changing how it selects the topics it will develop guidance on.
-
NICE & SIGN announce latest rapid Covid-19 guideline will address Long Covid
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) have today (5 October 2020) announced they will work with the Royal College of General Practitioners (RCGP) to develop a guideline on persistent effects of Covid-19 (Long Covid) on patients.
-
NICE board agrees to stimulate action following publication of Independent Medicines and Medical Devices Safety Review report
NICE to reinforce the importance of collaborative working with system partners to ensure a more integrated approach to safety recommendations made in NICE guidance
-
NICE announces autumn series of virtual events
Three webinar style events will feature a number of high-profile speakers
-
NICE joins global alliance to shine spotlight on evidence-based healthcare
Tuesday 20 October will be the inaugural World Evidence-based Healthcare Day
-
NICE's support for rebuilding capacity in non-COVID health services
Director of our Centre for Guidelines, Paul Chrisp, discusses how NICE can help the NHS and wider care sector restore services most affected by the COVID-19 pandemic
-
Call for abstracts for HTAi 2021 Annual Meeting in Manchester
Health Technology Assessment International (HTAi) has released the plenary themes for the HTAi 2021 Annual Meeting and opened their call for abstract submissions
-
NICE chief executive and chairman thank non-executive director for his service as he announces resignation
Professor Martin Cowie stands down from the NICE board following his appointment to a role at Astra Zeneca
-
Improved agreement means NICE now recommends lung cancer treatment
Thousands of people with non-small-cell lung cancer (NSCLC) will benefit from draft guidance published today by NICE.
-
Feeling safe and being heard in residential care is crucial
Dorothy Hodgkinson from Finding Perspectives discusses the importance of safeguarding adults in care homes
-
Nasal spray medicine for treatment-resistant depression not recommended by NICE
Consultation open on draft guidance until Friday 25 September 2020
-
Be aware of the signs of abuse and neglect in adult care homes, says NICE
Staff and visitors can play a vital role in the identification and prevention of abuse and neglect in care homes for adults says NICE, in a draft guideline published today.
-
Recruitment begins to fill up to seven non-executive roles on the NICE board
Roles will contribute to the development of NICE’s strategic objectives
-
New agreement means NICE recommends combination treatment for some lymphoma patients
Hundreds of people with a form of blood cancer will benefit from a new treatment following the publication of draft guidance by NICE.
-
NICE extends consultation period for new quality standard on fetal alcohol spectrum disorder
NICE has today (20 August, 2020), released its draft quality standard on fetal alcohol spectrum disorder (FASD) for further public consultation.